Emergency Abdominal Surgery

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AB
AP BiosciencesTaiwan - Taipei
1 program
Postoperative Intermediate CareN/A1 trial
Active Trials
NCT01209663TerminatedEst. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AP BiosciencesPostoperative Intermediate Care

Clinical Trials (1)

NCT01209663AP BiosciencesPostoperative Intermediate Care

Intermediate Care - Effect on Mortality Following Emergency Abdominal Surgery

Start: Oct 2010Est. completion: Dec 2012
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space